InsidersTradesSigma
Track the Stayble Therapeutics AB share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Market capitalisation: €13.2m. The latest transaction was disclosed on 22 April 2021 (Sale). Among the most active insiders: Kjell Olmarker. Every trade is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
Stayble Therapeutics AB is a biopharmaceutical company focused on developing treatments for chronic pain. It is listed on the XSTO exchange.